The mission of the platform is the establishment and evaluation of models for the understanding of molecular mechanisms of carcinogenesis and the improvement and development of innovative cancer therapies. All work is done in accordance with the 3Rs rule (replacement, reduction, refinement), and is officially authorised and validated by the ethics committee n°26, which is officially approved by the French Ministry of Research, all in compliance with the European Directive 2010/63 EU and its transposition into French law. The ethics committee n°26 covers the perimeter of the Faculties of Medicine and Pharmacy of the Université Paris-Sud.
114, rue Edouard Vaillant
Institut Gustave Roussy, UMS AMMICA